SEARCH

SEARCH BY CITATION

References

  • 1
    CFF. Cystic Fibrosis Foundation Patient Registry Annual Data Report. Bethesda, MD: CF Foundation, 2001.
  • 2
    Moran A, Hardin D, Rodman D et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999: 45: 6173.
  • 3
    Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998: 133: 1017.
  • 4
    Lanng S, Thorsteinsson B, Pociot F et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993: 82: 150154.
  • 5
    Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995: 311: 655659.
  • 6
    O’Riordan S, GA, Ennis S, George S, Hand E, Costigan C, Murphy N, Roche E, Hoey H. Genetics of cystic fibrosis related diabetes and non diabetes. Horm Res 2007: 68 (Suppl. 1): 4469. PO2-345 Proceedings from The European Society for Paediatric Endocrinology (ESPE). 2007 Helsinki 978-3-8055-8327-5: 1–283.
  • 7
    Rosenecker J, Eichler I, Kuhn L, Harms HK, Von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995: 127: 441443.
  • 8
    Koch C, Cuppens H, Rainisio M et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001: 31: 112.
  • 9
    Jensen P, Johansen HK, Carmi P, Hoiby N, Cohen IR. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis. J Autoimmun 2001: 17: 165172.
  • 10
    Derbel S, Doumaguet C, Hubert D et al. Calpain 10 and development of diabetes mellitus in cystic fibrosis. J Cyst Fibros 2006: 5: 4751.
  • 11
    Couce M, O’Brien TD, Moran A, Roche PC, Butler PC. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996: 81: 12671272.
  • 12
    Lohr M, Goertchen P, Nizze H et al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol 1989: 414: 179185.
  • 13
    Iannucci A, Mukai K, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984: 15: 278284.
  • 14
    Lanng S, Thorsteinsson B, Pociot F et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993: 82: 150154.
  • 15
    Dobson L, Sheldon CD, Hattersley AT. Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency? J R Soc Med 2004: 97 (Suppl. 44): 2635.
  • 16
    Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004: 21: 691696.
  • 17
    Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995: 154: 356361.
  • 18
    Lanng S, Thorsteinsson B, Roder ME et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993: 128: 207214.
  • 19
    De Schepper J, Dab I, Derde MP, Loeb H. Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations. Eur J Pediatr 1991: 150: 403406.
  • 20
    Hamdi I, Green M, Shneerson JM, Palmer CR, Hales CN. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin Endocrinol (Oxf) 1993: 39: 2126.
  • 21
    Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 2002: 19: 221226.
  • 22
    Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991: 118: 715723.
  • 23
    Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994: 43: 163167.
  • 24
    Cucinotta D, De Luca F, Gigante A et al. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994: 130: 253258.
  • 25
    Lombardo F, De Luca F, Rosano M et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003: 149: 5359.
  • 26
    Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER. Insulin sensitivity in cystic fibrosis. Diabetes 1994: 43: 10201026.
  • 27
    Hardin DS, LeBlanc A, Lukenbough S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997: 130: 948956.
  • 28
    Hardin DS, Leblanc A, Marshall G, Seilheimer DK. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001: 281: E1022E1028.
  • 29
    Bismuth E, Laborde K, Taupin P et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008: 152: 540545, 5 e1.
  • 30
    Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child 1991: 66: 612616.
  • 31
    Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005: 146: 681687.
  • 32
    Finkelstein SM, Wielinski CL, Elliott GR et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988: 112: 373377.
  • 33
    Koch C, Rainisio M, Madessani U et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001: 32: 343350.
  • 34
    Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992: 151: 684687.
  • 35
    Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000: 162: 891895.
  • 36
    Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001: 90: 515519.
  • 37
    Rolon MA, Benali K, Munck A et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001: 90: 860867.
  • 38
    Rosenecker J, Hofler R, Steinkamp G et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res. 2001: 6: 345350.
  • 39
    Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005: 28: 21412144.
  • 40
    Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994: 83: 7277.
  • 41
    Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989: 84: 642647.
  • 42
    Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998: 92: 871872.
  • 43
    Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes - The presence of microvascular diabetes complications. Diabetes Care 2006: 29: 26602663.
  • 44
    Schwarzenberg SJ, Thomas W, Olsen TW et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007: 30: 10561061.
  • 45
    De Luca F, Arrigo T, Conti Nibali S et al. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 1991: 23: 495498.
  • 46
    Littlewood J BN, Hodson M et al. Management of Cystic Fibrosis Related Diabetes Mellitus – Report of the UK Cystic Fibrosis Trust Diabetes Working Group. Bromley Kent, UK: Cystic Fibrosis Trust, 2004.
  • 47
    Jefferies C, Solomon M, Perlman K, Sweezey N, Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005: 147: 396398.
  • 48
    O’Riordan S, Hoey H, George S, Costigan C. Can continuous glucose monitoring enhance the detection of CFRD in 167 cystic fibrosis children. Diabetes 2006: 55: 224.
  • 49
    O’Riordan S, Roche E, George S, Hoey H, Costigan C. Continuous glucose monitoring enhances the detection of cystic fibrosis related diabetes in children with cystic fibrosis. Diabetologia 2007: 50 (Suppl. 1): OP 32, 0190:S1S538.
  • 50
    Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003: 26: 19401941.
  • 51
    Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002: 35: 246259.
  • 52
    Reisman J, Corey M, Canny G, Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 1990: 86: 374377.
  • 53
    Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002: 87: 430431.
  • 54
    Grover P, Thomas W, Moran A. Glargine versus NPH insulin in cystic fibrosis related diabetes. J Cyst Fibros 2008: 7: 134136.
  • 55
    Sulli N, Bertasi S, Zullo S, Shashaj B. Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports. J Cyst Fibros 2007: 6: 237240.
  • 56
    Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA(1c) with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003: 16: 393399.
  • 57
    Onady GM, Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2005: CD004730.
  • 58
    Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001: 24: 17061710.
  • 59
    Sheppard DN, Welsh MJ. Effect of ATP-sensitive K+ channel regulators on cystic-fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 1992: 100: 573591.
  • 60
    Rosenecker J, Eichler I, Barmeier H, Von DerHardt H. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001: 32: 351355.
  • 61
    Hardin DS, Rice J, Cohen RC, Ellis KJ, Nick JA. The metabolic effects of pregnancy in cystic fibrosis. Obstet Gynecol 2005: 106: 367375.